作者：Spero Therapeutics(SPRO)
| 发布于: | 公告 | 转发：0 | 回复：0 | 喜欢：0 |
$Spero治疗(SPRO)$ 8-K - Current report Filed: 2019-05-09 AccNo: 0001193125-19-142982 Size: 57 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接